Core Scientific, Inc./tx 8K

Core Scientific, Inc. entered into $600 million of senior secured credit facilities expected to free $300 million of restricted cash and enhance its liquidity and financial flexibility.

Core Scientific, Inc. announced that on August 27, 2026 it entered into $600 million of committed senior secured credit facilities, comprised of a $100 million revolving credit facility and a $500 million letter of credit facility, to be used for general corporate purposes, working capital, and credit support for project-related utility agreements, with terms including a three-year maturity on the revolver, interest at Adjusted Term SOFR plus 1.75% or an alternate base rate plus 0.75%, and 1.75% annual fees plus a 0.125% fronting fee on letters of credit; the facilities are guaranteed by certain wholly owned domestic subsidiaries and secured by a first-priority lien on substantially all assets, are expected to release approximately $300 million of restricted cash and improve capital efficiency and financial flexibility, and were arranged and syndicated among Morgan Stanley Senior Funding, Inc., JPMorgan Chase Bank, N.A., Goldman Sachs, and TD Securities (USA) LLC in various agent and bookrunner roles.

Filing Facts

CIK

1839341

Ticker

-

Form

8K

Source Type

sec

Accession

0001839341-26-000021

Alert Tier

7